Literature DB >> 6389237

Favourable outcome of hepatic veno-occlusive disease in a renal transplant patient receiving azathioprine, treated by portacaval shunt. Report of a case and review of the literature.

T Eisenhauer, H Hartmann, K W Rumpf, U Helmchen, F Scheler, W Creutzfeldt.   

Abstract

Veno-occlusive disease (VOD) developed in a 45-year-old white male 2 years after cadaveric kidney transplantation while receiving combined immunosuppressive therapy with prednisone and azathioprine. Early clinical signs at presentation included ascites and tender hepatomegaly. The diagnosis of VOD was established at laparoscopy and by histological examination of liver biopsies. Azathioprine was discontinued. Gross ascites refractory to medical treatment and decreasing liver function required surgical treatment by portacaval shunt. Transient postoperative complications were hepatic encephalopathy and considerable hyperbilirubinaemia. 8 months later the patient is well, with stable renal function and no clinical signs of hepatic disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6389237     DOI: 10.1159/000199104

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  4 in total

1.  Venoocclusive disease of the liver following renal transplantation.

Authors:  M A Jeffries; W M McDonnell; J A Tworek; R M Merion; R H Moseley
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

2.  Peliosis hepatis induced by 6-thioguanine administration.

Authors:  D Larrey; E Fréneaux; A Berson; G Babany; C Degott; D Valla; D Pessayre; J P Benhamou
Journal:  Gut       Date:  1988-09       Impact factor: 23.059

3.  Idiopathic portal hypertension in a renal transplant patient after long-term azathioprine therapy.

Authors:  R Lorenz; M Brauer; M Classen; N Tornieporth; K Becker
Journal:  Clin Investig       Date:  1992-02

Review 4.  Management of hepatic vein occlusive disease after liver transplantation: A case report with literature review.

Authors:  Yuchen Hou; Nga Lei Tam; Zhicheng Xue; Xuzhi Zhang; Bing Liao; Jie Yang; Shunjun Fu; Yi Ma; Linwei Wu; Xiaoshun He
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.